Expression of Estrogen Receptor Beta Predicts Oncologic Outcome of pT3 Upper Urinary Tract Urothelial Carcinoma Better Than Aggressive Pathological Features.
Ontology highlight
ABSTRACT: Upper urinary tract urothelial carcinoma (UT-UC) is rare and treatment options or prognostic markers are limited. There is increasing evidence indicating that urothelial carcinoma may be an endocrine-related cancer. The aim of this study was to analyze the prognostic effect of estrogen receptor beta (ER?) on the outcome of UT-UC. From 2005 to 2012, this study included 105 patients with pT3 UT-UC. Perioperative factors, pathological features, and ER? immunostaining were reviewed and prognostic effects were examined by multivariate analysis. This study divided patients into either the ER?-high (n = 52) or ER?-low (n = 53) group and analyzed their oncologic outcomes. All pathological features except infiltrating tumor architecture (significantly higher incidence in ER?-low group, p = 0.004) are symmetric in both groups. Low ER? expression was significantly correlated with local recurrence and distant metastasis in univariate analysis (p = 0.035 and 0.004, respectively) and multivariate analysis (p = 0.05 and 0.008, respectively). Cell line study also proved that knock down of ER? cause less UTUC proliferation and migration. In addition, ER? agonist also enhanced the cytotoxic and migration inhibition effect of cisplatin and ER? antagonist cause the UTUC cell more resistant to cisplatin. This result may help identify patients in need of adjuvant therapy or develop potential targeted therapy.
SUBMITTER: Luo HL
PROVIDER: S-EPMC4823660 | biostudies-literature | 2016 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA